Anti-CD20 antibody induces the improvement of cytokine-induced killer cell activity via the STAT and MAPK/ERK signaling pathways

There is a current requirement for novel therapeutic strategies for the treatment of hematopoietic tumors. Residual tumor cells are the main origin of tumor relapse. The aim of this study was to eliminate the residual tumor cells of hematopoietic tumors. Cytokine-induced killer (CIK) cells are used...

全面介紹

Na minha lista:
書目詳細資料
發表在:Exp Ther Med
Main Authors: DENG, QI, BAI, XUE, LV, HAI-RONG, XIAO, XIA, ZHAO, MING-FENG, LI, YU-MING
格式: Artigo
語言:Inglês
出版: D.A. Spandidos 2015
主題:
Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4353788/
https://ncbi.nlm.nih.gov/pubmed/25780412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2015.2264
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍